IMMUNOSENS Co. Ltd. announced that it has received a round of funding on July 26, 2023. The transaction included participation from new investor, Shimadzu Future Innovation Fund L.P., a fund co-managed by Global Brain Co., Ltd., and Shimadzu Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,354 JPY | -0.50% | +0.86% | +10.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.45% | 8.29B | |
-3.84% | 4.68B | |
-8.31% | 2.91B | |
+5.67% | 2.15B | |
-25.01% | 1.2B | |
-1.50% | 898M | |
-7.09% | 807M | |
-22.40% | 791M | |
-23.70% | 698M | |
-58.00% | 698M |
- Stock Market
- Equities
- 7701 Stock
- News Shimadzu Corporation
- IMMUNOSENS Co. Ltd. announced that it has received funding from Global Brain Co., Ltd., Shimadzu Corporation